SPARC announces top-line results of Pivotal Bioequivalence Study
With the launch of novel formulations, market for nano-formulations of Paclitaxel is expected to grow
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Home » Latest Updates » Page 111
Browsing Category
Latest Updates
Glenmark receives tentative ANDA approval for Clobetasol Propionate Foam
The company continues to identify and explore external development partnerships to supplement and accelerate the growth
Canadian delegation to showcase investment opportunities to India
The delegation will visit Bengaluru and Mumbai from November 26 to 30
Lupin launches chatbot ANYA
ANYA is the first bot of its kind to be launched in India for disease awareness
ABLE’s BioEconomy Conclave to be held in Bengaluru
The two-day conclave from January 31 to Febrauary 1, will have nine sessions dedicated to different segments of bioeconomy
Strides board approves $15 m investment in Stelis Biopharma
The first close of the current fund raise is $35 million, of which Strides will commit $15 million and $20 million is from other…
Roche-AbbVie cancer drug gets accelerated FDA approval
The drug, developed in partnership with AbbVie, was approved for patients with acute myeloid leukemia
US FDA approves new blood cancer treatment from Pfizer
The company plans to launch the drug, Daurismo, in the US by early December with a monthly list price of $16,925
Indoco’s Goa Plant II & III clears US FDA inspection
This positive development will now pave the way for approval of our pending ANDAs with consequent boost to revenues from the US…
Environmental exposures early in life modify immune responses
Studies have shown that immunological development and maturation starts already during pregnancy and in early childhood